Applied Opt (AAOI) had the highest return between June 12, 2023 and September 1, 2023 by a small-cap US stock, returning 335.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Applied Opt (AAOI) | 6/12/2023 - 9/1/2023 | 335.63% |
Spyre Therapeutics (SYRE) | 6/12/2023 - 9/1/2023 | 326.47% |
Taysha Gene Therapies (TSHA) | 6/12/2023 - 9/1/2023 | 322.09% |
ASP Isotopes Inc Common Stock (ASPI) | 6/12/2023 - 9/1/2023 | 174% |
Telesat (TSAT) | 6/12/2023 - 9/1/2023 | 140.25% |
Akso Health Group ADR (AHG) | 6/12/2023 - 9/1/2023 | 127.4% |
Groupon (GRPN) | 6/12/2023 - 9/1/2023 | 126.78% |
Neuropace (NPCE) | 6/12/2023 - 9/1/2023 | 118.34% |
Vera Therapeutics (VERA) | 6/12/2023 - 9/1/2023 | 115.58% |
Tetra Technologies (TTI) | 6/12/2023 - 9/1/2023 | 100.35% |
Pagaya Technologies (PGY) | 6/12/2023 - 9/1/2023 | 95.12% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 6/12/2023 - 9/1/2023 | 91.54% |
Fulcrum Therapeutics (FULC) | 6/12/2023 - 9/1/2023 | 89.4% |
Gyre Therapeutics (GYRE) | 6/12/2023 - 9/1/2023 | 87.5% |
Tilray (TLRY) | 6/12/2023 - 9/1/2023 | 86.88% |
Pharvaris (PHVS) | 6/12/2023 - 9/1/2023 | 86.69% |
Orion (ORN) | 6/12/2023 - 9/1/2023 | 81.78% |
Ehang (EH) | 6/12/2023 - 9/1/2023 | 78.97% |
Oric Pharmaceuticals (ORIC) | 6/12/2023 - 9/1/2023 | 75.09% |
Eyepoint Pharmaceuticals (EYPT) | 6/12/2023 - 9/1/2023 | 71.9% |
Acm Research (ACMR) | 6/12/2023 - 9/1/2023 | 69.86% |
TheRealReal (REAL) | 6/12/2023 - 9/1/2023 | 67.66% |
Lifeway Foods (LWAY) | 6/12/2023 - 9/1/2023 | 67.53% |
Waldencast Acquisition (WALDW) | 6/12/2023 - 9/1/2023 | 66.67% |
American Superconductor (AMSC) | 6/12/2023 - 9/1/2023 | 66.55% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
